GMP Inspection Results Can No Longer Stay Within Borders, Says FDA

Results from manufacturing facility inspections conducted in one country will easily be shared with regulators in another in the near term, says Larry Kessler, FDA officer and chair of the Global Harmonization Task Force

More from Archive

More from Medtech Insight